Commerzbank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $316K | Sell |
506
-33
| -6% | -$22.5K | 0.01% | 297 |
|
|
2026
Q1 | $416K | Sell |
539
-39
| -7% | -$29.9K | 0.01% | 277 |
|
|
2025
Q4 | $446K | Hold |
578
| – | – | 0.01% | 290 |
|
|
2025
Q3 | $325K | Sell |
578
-23
| -4% | -$13K | 0.01% | 302 |
|
|
2025
Q2 | $316K | Hold |
601
| – | – | 0.01% | 297 |
|
|
2025
Q1 | $382K | Hold |
601
| – | – | 0.01% | 262 |
|
|
2024
Q4 | $423K | Buy |
601
+199
| +50% | +$167K | 0.01% | 236 |
|
|
2024
Q3 | $423K | Buy |
402
+171
| +74% | +$190K | 0.01% | 209 |
|
|
2024
Q2 | $243K | Buy |
+231
| New | +$224K | 0.01% | 218 |
|
|
2020
Q2 | – | Sell |
-6,287
| Closed | -$3.07M | – | 342 |
|
|
2020
Q1 | $3.07M | Sell |
6,287
-3,435
| -35% | -$1.42M | 0.14% | 93 |
|
|
2019
Q4 | $3.65M | Sell |
9,722
-19,989
| -67% | -$6.73M | 0.04% | 252 |
|
|
2019
Q3 | $8.24M | Buy |
29,711
+2,685
| +10% | +$795K | 0.06% | 214 |
|
|
2019
Q2 | $8.46M | Sell |
27,026
-3,808
| -12% | -$1.27M | 0.07% | 219 |
|
|
2019
Q1 | $12.7M | Buy |
30,834
+2,880
| +10% | +$1.19M | 0.12% | 147 |
|
|
2018
Q4 | $10.4M | Buy |
27,954
+400
| +1% | +$146K | 0.11% | 161 |
|
|
2018
Q3 | $11.1M | Buy |
27,554
+11,776
| +75% | +$4.48M | 0.1% | 169 |
|
|
2018
Q2 | $5.44M | Sell |
15,778
-23,873
| -60% | -$7.47M | 0.05% | 263 |
|
|
2018
Q1 | $13.7M | Buy |
39,651
+3,363
| +9% | +$1.17M | 0.14% | 140 |
|
|
2017
Q4 | $13.6M | Sell |
36,288
-5,656
| -13% | -$2.29M | 0.16% | 122 |
|
|
2017
Q3 | $18.8M | Buy |
41,944
+15,395
| +58% | +$7.33M | 0.25% | 98 |
|
|
2017
Q2 | $13M | Buy |
26,549
+6,229
| +31% | +$2.73M | 0.22% | 104 |
|
|
2017
Q1 | $7.87M | Sell |
20,320
-4,109
| -17% | -$1.52M | 0.12% | 162 |
|
|
2016
Q4 | $8.97M | Buy |
24,429
+1,847
| +8% | +$702K | 0.13% | 143 |
|
|
2016
Q3 | $9.08M | Sell |
22,582
-172
| -0.8% | -$69K | 0.15% | 133 |
|
|
2016
Q2 | $7.95K | Sell |
22,754
-582
| -2% | -$224K | 0.05% | 185 |
|
|
2016
Q1 | $8.41M | Sell |
23,336
-27,626
| -54% | -$11.4M | 0.07% | 164 |
|
|
2015
Q4 | $27.7M | Buy |
50,962
+6,996
| +16% | +$3.79M | 0.21% | 93 |
|
|
2015
Q3 | $20.4M | Sell |
43,966
-22,413
| -34% | -$12M | 0.15% | 108 |
|
|
2015
Q2 | $33.9M | Buy |
66,379
+3,298
| +5% | +$1.61M | 0.18% | 87 |
|
|
2015
Q1 | $28.5M | Sell |
63,081
-11,913
| -16% | -$5.05M | 0.17% | 99 |
|
|
2014
Q4 | $30.8M | Buy |
74,994
+933
| +1% | +$367K | 0.2% | 97 |
|
|
2014
Q3 | $26.7M | Buy |
74,061
+3,112
| +4% | +$1.04M | 0.11% | 147 |
|
|
2014
Q2 | $20M | Buy |
70,949
+15,520
| +28% | +$4.6M | 0.1% | 154 |
|
|
2014
Q1 | $16.6M | Buy |
55,429
+5,976
| +12% | +$1.84M | 0.07% | 173 |
|
|
2013
Q4 | $14.3M | Sell |
49,453
-6,400
| -11% | -$1.84M | 0.07% | 195 |
|
|
2013
Q3 | $17.5M | Buy |
55,853
+8,593
| +18% | +$2.26M | 0.09% | 182 |
|
|
2013
Q2 | $10.6M | Buy |
+47,260
| New | +$11M | 0.05% | 299 |
|
Other funds holding REGN
N
Commerzbank Aktiengesellschaft's REGN Position: Q2 2026 in Review
Commerzbank Aktiengesellschaft reduced its Regeneron Pharmaceuticals (REGN) stake by 6.1% in Q2 2026, selling an estimated $22.5K and leaving 506 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #297.
Commerzbank Aktiengesellschaft first reported a position in REGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $33.9M in Q2 2015. 797 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Commerzbank Aktiengesellschaft held 506 shares of Regeneron Pharmaceuticals worth $316K as of Q2 2026.
- Commerzbank Aktiengesellschaft sold 33 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $22.5K.
- Regeneron Pharmaceuticals made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #297 holding.
- Commerzbank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 37 quarters since.
- Commerzbank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $33.9M in Q2 2015.
- 797 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.